Target intelligence / Profile preview

Microsomal glutathione S-transferase 3 (MGST3)

Target
MGST3
Molecular classification
Enzyme, Glutathione S-transferase, Membrane-associated protein in eicosanoid and glutathione metabolism (MAPEG family)
01

Overview

Microsomal glutathione S-transferase 3 (MGST3) is a membrane-associated enzyme of the glutathione S-transferase superfamily, classified within the MAPEG family. It plays a central role in cellular detoxification by catalyzing the conjugation of reduced glutathione to reactive lipid peroxidation products and xenobiotic electrophiles, reducing oxidative cellular damage. MGST3 demonstrates both glutathione transferase and peroxidase activities, notably in the biosynthesis of leukotriene C4 and the reduction of lipid hydroperoxides. MGST3 is implicated in inflammation and neuroanatomical modulation, with genetic variability affecting susceptibility to neurodegenerative and inflammatory diseases. Its enzymatic activity is essential for regulating oxidative stress and maintaining neuronal health[1][3][4].

Other names
GST-IIIglutathione S-transferase 3, mitochondrialmicrosomal glutathione S-transferase IIILTC4 synthase MGST3glutathione peroxidase MGST3microsomal GST-3micrososomal GST-III
02

Mechanism of action

Drugs that inhibit or modulate MGST3 would alter cellular detoxification of electrophilic compounds and lipid peroxides, and may influence eicosanoid/inflammatory mediator biosynthesis. Agents targeting glutathione S-transferase activity could impact oxidative stress response.

03

Biological functions

Cellular detoxificationProtection against oxidative stressGlutathione transferase activityGlutathione-dependent peroxidase activityBiosynthesis of leukotrienes and prostaglandinsConjugation of leukotriene A4 and reduced glutathione (synthesis of leukotriene C4)
04

Disease associations

InflammationPulmonary disease (notably chronic obstructive pulmonary disease)Neurodegenerative disease (genetic variability linked to hippocampal size and vulnerability)Other (modulation of oxidative stress–related pathologies)
05

Safety considerations

Altering MGST3 function could affect normal detoxification pathways, potentially leading to increased cellular susceptibility to oxidative or chemical-induced damage.Impact on inflammatory mediator production (e.g., leukotrienes) could lead to off-target effects.

Beyond the preview

Go deeper on Microsomal glutathione S-transferase 3 (MGST3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microsomal glutathione S-transferase 3 (MGST3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call